期刊
TRANSCRIPTION-AUSTIN
卷 10, 期 2, 页码 57-75出版社
TAYLOR & FRANCIS INC
DOI: 10.1080/21541264.2018.1523668
关键词
Enhancer; CDK9; P-TEFb; 7SK; RNA polymerase II; Transcription; Pausing; Elongation; Cancer; HIV; Disease
资金
- National Institute of Allergy and Infectious Diseases [R01AI114362, R33AI116222]
- National Science Foundation [2016220513]
- Welch Foundation [I-1872]
Cyclin-dependent kinase 9 (CDK9) is critical for RNA Polymerase II (Pol II) transcription initiation, elongation, and termination in several key biological processes including development, differentiation, and cell fate responses. A broad range of diseases are characterized by CDK9 malfunction, illustrating its importance in maintaining transcriptional homeostasis in basal- and signal-regulated conditions. Here we provide a historical recount of CDK9 discovery and the current models suggesting CDK9 is a central hub necessary for proper execution of different steps in the transcription cycle. Finally, we discuss the current therapeutic strategies to treat CDK9 malfunction in several disease states.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据